Enanta Pharmaceuticals, Inc. (ENTA)
13.41
-0.40
(-2.90%)
USD |
NASDAQ |
May 15, 16:00
13.46
+0.06
(+0.41%)
After-Hours: 20:00
Enanta Pharmaceuticals Market Cap : 389.94M for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cyclerion Therapeutics, Inc. | 13.51M |
| Keros Therapeutics, Inc. | 207.81M |
| ACADIA Pharmaceuticals, Inc. | 3.664B |
| Alnylam Pharmaceuticals, Inc. | 38.32B |
| Amgen, Inc. | 176.21B |
Market Cap Related Metrics
| PS Ratio | 4.870 |
| Price to Book Value | 3.345 |
| Price | 13.41 |
| Earnings Yield | -19.35% |